Last10K.com

Beckman Coulter Inc (BEC) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2008

Beckman Coulter Inc

HISTORY TOOLS
CIK: 840467 Ticker: BEC

Exhibit 99.1

 

LOGO      
      NEWS RELEASE
Contact:   Cynthia Skoglund       (714) 773-7620
  Manager, Investor Relations      

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results;

Earnings Outlook Achieved on Strong Fundamentals

ORANGE COUNTY, California, February 9, 2009 – Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today fourth quarter and year ended December 31, 2008 results. For the fourth quarter, total revenue was $811.3 million, up 2.8%, on robust sales to Clinical Diagnostics customers, partially offset by a decline in Life Sciences revenue. In constant currency, revenue increased 6.6%. Reported net earnings increased to $77.2 million, or $1.21 per fully diluted share. Adjusted net earnings increased to $82.3 million, or $1.29 per fully diluted share.

 

     Quarter Ended
December 31,		    Year Ended
December 31,
            2008                  2007                % Chg         2008    2007         % Chg     

Reported Results (in millions)

                  

Revenue

    $ 811.3        $ 789.0        2.8%        $ 3,098.9        $ 2,761.3        12.2%     

Operating Income

    $ 115.1        $ 74.6        54.3%        $ 298.6        $ 272.4        9.6%     

Diluted Earnings per Share

                  

Continuing Operations

    $ 1.21        $ 0.69        75.4%        $ 3.01        $ 3.27        (8.0)%    

Discontinued Operations

      —            —          —               —            0.03        —         
                                     

Diluted Earnings per Share

    $ 1.21        $ 0.69        75.4%        $ 3.01        $ 3.30        (8.8)%    

Adjusted Results Excluding Special Items*

                  

Operating Income

    $ 123.3        $ 114.2        8.0%        $ 363.7        $ 327.1        11.2%     

Diluted Earnings per Share

    $ 1.29        $ 1.08        19.4%        $ 3.63        $ 3.25        11.7%     

 

* See “Non-GAAP Financial Measures,” where the impacts of certain items on reported results are discussed.

 

- more -

The following information was filed by Beckman Coulter Inc (BEC) on Monday, February 9, 2009 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Beckman Coulter Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Beckman Coulter Inc.

Continue

Assess how Beckman Coulter Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Beckman Coulter Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: BEC
CIK: 840467
Form Type: 10-K Annual Report
Accession Number: 0001193125-09-035204
Submitted to the SEC: Mon Feb 23 2009 5:15:37 PM EST
Accepted by the SEC: Mon Feb 23 2009
Period: Wednesday, December 31, 2008
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/bec/0001193125-09-035204.htm